The General Hospital Corporation: Drug Recall
Recall #D-0288-2021 · 02/17/2021
Class II: Risk
Recall Details
- Recall Number
- D-0288-2021
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- The General Hospital Corporation
- Status
- Terminated
- Date Initiated
- 02/17/2021
- Location
- Boston, MA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 50 mL vial
Reason for Recall
Lack of Assurance of Sterility
Product Description
Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50
Distribution Pattern
Product was distributed to one direct account.
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.